Identification of differentially expressed genes in human embryonic stem cell-derived endothelial cells using suppression subtractive hybridization

Stem Cells and Development

Volumn 19, Issue 8, 2010, Pages 1249-1256

  Ahn, Jin Seop ^a   Moon, Sung Hwan ^b   Kim, Jumi ^b   Chung, Hyung Min ^b   Kim, Jin Kyeoung ^a  

^a CHA University   (South Korea)

^b CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEAT SHOCK PROTEIN;

ARTICLE; BIOINFORMATICS; CELL ADHESION; CELL MATURATION; CELL METABOLISM; CYTOSKELETON; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENDOTHELIUM PROGENITOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; IMMUNOCYTOCHEMISTRY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION;

ANTIGENS, CD31; CELL DIFFERENTIATION; CELL LINE; CELL SHAPE; DNA, COMPLEMENTARY; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LIPOPROTEINS, LDL; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEIC ACID HYBRIDIZATION; OCTAMER TRANSCRIPTION FACTOR-3; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON WILLEBRAND FACTOR;

EID: 77956313484     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0265     Document Type: Article

References (21)

1. Iozzo RV, I Eichstetter and KG Danielson. (1995). Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55:3495-3499.
2. Kocher AA, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards and S Itescu. (2001). Neovascularization of ischemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
3. Ma N, C Stamm, A Kaminski, W Li, HD Kleine, B Muller-Hilke, L Zhang, Y Ladilov, D Egger and G Steinhoff. (2005). Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc Res 66:45-54.
4. Kawamoto A, HC Gwon, H Iwaguro, JI Yamaguchi, S Uchida, H Masuda, M Silver, H Ma, M Kearney, JM Isner and T Asahara. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637.
5. Rafi S and D Lyden. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
6. Miller-Kasprzak E and PP Jagodzinski. (2007). Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz) 55:247-259.
7. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
8. Hur J, CH Yoon, HS Kim, JH Choi, HJ Kang, KK Hwang, BH Oh, MM Lee and YB Park. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
9. Aoki M, M Yasutake and T Murohara. (2004). Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell fi ltration device. Stem Cells 22:994-1002.
10. Urbich C and S Dimmeler. (2004). Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
11. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
12. Cho SW, SH Moon, SH Lee, SW Kang, J Kim, JM Lim, HS Kim, BS Kim and HM Chung. (2007). Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116:2409-2419.
13. Diatchenko L, YF Lau, AP Campbell, A Chenchik, F Moqadam, B Huang, S Lukyanov, K Lukyanov, N Gurskaya, ED Sverdlov and PD Siebert. (1996). Suppression subtractive hybridization: a method for generating differentially regulated or tissuespecifi c cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025-6030.
14. Hynes RO and KM Yamada. (1982). Fibronectins: multifunctional modular glycoproteins. J Cell Biol 95(2 Pt 1):369-377.
15. Jaffe EA and DF Mosher. (1978). Synthesis of fi bronectin by cultured human endothelial cells. J Exp Med 147:1779-1791.
16. McMahon GA, E Petitclerc, S Stefansson, E Smith, MK Wong, RJ Westrick, D Ginsburg, PC Brooks and DA Lawrence. (2001). Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276:33964-33968.
17. Takayanagi S, T Hiroyama, S Yamazaki, T Nakajima, Y Morita, J Usui, K Eto, T Motohashi, K Shiomi, K Keino-Masu, M Masu, Y Oike, S Mori, N Yoshida, A Iwama and H Nakauchi. (2006). Genetic marking of hematopoietic stem and endothelial cells: identification of the Tmtsp gene encoding a novel cell surface protein with the thrombospondin-1 domain. Blood 107:4317-4325.
18. Lawler J. (2002). Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6:1-12.
19. Wunderlich K, BC Senn, L Todesco, J Flammer and P Meyer. (2000). Regulation of connective tissue growth factor gene expression in retinal vascular endothelial cells by angiogenic growth factors. Graefes Arch Clin Exp Ophthalmol 238:910-915.
20. Takahashi S, SV Reddy, JM Chirgwin, R Devlin, C Haipek, J Anderson and GD Roodman. (1994). Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 269:28696-28701.
21. Lane TF, ML Iruela-Arispe and EH Sage. (1992). Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fi bronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 267:16736-16745.